William Hawkins, the former Chairman and CEO of Medtronic, has a new job.

He’s the CEO of Immucor Inc., an Atlanta-based company that sells systems that detect cell and serum components of blood prior to transfusion. The transition will be effective Oct. 17.

Hawkins, 57, left Medtronic last spring after Omar Ishrak was named CEO of the Fridley-based med-tech giant.

Privately held Immucor is owned by TPG Capital.

Janet Moore covers medical technology for the Star Tribune.